Moderna Inc.’s COVID-19 vaccine appeared to be set for regulatory authorization this week after U.S. Food and Drug Administration staff members did not raise any major new concerns about it in documents released on Tuesday. The FDA reviewers said a …
from News – Insurance Journal https://ift.tt/3mfgSB2
via
IFTTT
No comments:
Post a Comment